Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of bioactive molecules targeting central nervous system disorders. Its structural features enable selective modulation of neurotransmitter receptors, making it valuable in medicinal chemistry for creating analogs with improved metabolic stability and binding affinity. The compound's ester groups allow for further functionalization, facilitating the preparation of diverse compound libraries for drug discovery. Additionally, its rigid pyrrolidine scaffold contributes to conformational restraint, enhancing target selectivity in therapeutic candidates.